BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33274599)

  • 1. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
    Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
    Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Ben-Menachem S; Zaritsky A; Ehrlich M; Prieto VG; Bar-Eli M; Pirker C; Berger W; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Int J Cancer; 2015 Mar; 136(6):1296-307. PubMed ID: 25046141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis Suppressor NME1 Directly Activates Transcription of the
    Pamidimukkala NV; Leonard MK; Snyder D; McCorkle JR; Kaetzel DM
    Anticancer Res; 2018 Nov; 38(11):6059-6068. PubMed ID: 30396920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
    Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
    Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer.
    Maruyama R; Nagaoka Y; Ishikawa A; Akabane S; Fujiki Y; Taniyama D; Sentani K; Oue N
    Pathol Int; 2022 Mar; 72(3):176-186. PubMed ID: 35147255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
    Marzese DM; Liu M; Huynh JL; Hirose H; Donovan NC; Huynh KT; Kiyohara E; Chong K; Cheng D; Tanaka R; Wang J; Morton DL; Barkhoudarian G; Kelly DF; Hoon DS
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):82-93. PubMed ID: 25169209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.
    Neuditschko B; Janker L; Niederstaetter L; Brunmair J; Krivanek K; Izraely S; Sagi-Assif O; Meshel T; Keppler BK; Del Favero G; Witz IP; Gerner C
    Mol Cell Proteomics; 2020 Mar; 19(3):478-489. PubMed ID: 31892524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
    Ramos RI; Bustos MA; Wu J; Jones P; Chang SC; Kiyohara E; Tran K; Zhang X; Stern SL; Izraely S; Sagi-Assif O; Witz IP; Davies MA; Mills GB; Kelly DF; Irie RF; Hoon DSB
    Mol Oncol; 2020 Aug; 14(8):1760-1778. PubMed ID: 32358995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of fructose-bisphosphate aldolase C expression as a predictor of advanced oral squamous cell carcinoma.
    Li YJ; Huang TH; Hsiao M; Lin BR; Cheng SJ; Yang CN; Lai WT; Wu TS; Fan JR; Kuo MY; Chang CC
    Head Neck; 2016 Apr; 38 Suppl 1():E1075-85. PubMed ID: 26565993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR4 is a determinant of melanoma brain metastasis.
    Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
    Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth.
    Fan K; Wang J; Sun W; Shen S; Ni X; Gong Z; Zheng B; Gao Z; Ni X; Suo T; Liu H; Liu H
    Exp Cell Res; 2020 Sep; 394(1):112118. PubMed ID: 32502493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
    Pozzi S; Scomparin A; Ben-Shushan D; Yeini E; Ofek P; Nahmad AD; Soffer S; Ionescu A; Ruggiero A; Barzel A; Brem H; Hyde TM; Barshack I; Sinha S; Ruppin E; Weiss T; Madi A; Perlson E; Slutsky I; Florindo HF; Satchi-Fainaro R
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35980743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway.
    Izraely S; Ben-Menachem S; Malka S; Sagi-Assif O; Bustos MA; Adir O; Meshel T; Chelladurai M; Ryu S; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Cells; 2023 May; 12(11):. PubMed ID: 37296634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL-X
    Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
    Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
    Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
    Stejerean-Todoran I; Gimotty PA; Watters A; Brafford P; Krepler C; Godok T; Li H; Bonilla Del Rio Z; Zieseniss A; Katschinski DM; Sertel SM; Rizzoli SO; Garman B; Nathanson KL; Xu X; Chen Q; Oswald JH; Lotem M; Mills GB; Davies MA; Schön MP; Bogeski I; Herlyn M; Vultur A
    Neuro Oncol; 2023 Apr; 25(4):674-686. PubMed ID: 36054930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.